Having made breakthroughs—looking inside Alzheimer’s disease brains, watching stem cells work in the gut—Nozomi Nishimura will now watch cancer cells.

Concentrating on human genomic and epigenetic processes, Ari Melnick studies lymphomas and leukemias—searching for effectual, targeted therapeutics.